These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
703 related items for PubMed ID: 21835320
1. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. Olivotto I, Girolami F, Sciagrà R, Ackerman MJ, Sotgia B, Bos JM, Nistri S, Sgalambro A, Grifoni C, Torricelli F, Camici PG, Cecchi F. J Am Coll Cardiol; 2011 Aug 16; 58(8):839-48. PubMed ID: 21835320 [Abstract] [Full Text] [Related]
2. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. Girolami F, Ho CY, Semsarian C, Baldi M, Will ML, Baldini K, Torricelli F, Yeates L, Cecchi F, Ackerman MJ, Olivotto I. J Am Coll Cardiol; 2010 Apr 06; 55(14):1444-53. PubMed ID: 20359594 [Abstract] [Full Text] [Related]
5. Mutations in sarcomere protein genes in left ventricular noncompaction. Klaassen S, Probst S, Oechslin E, Gerull B, Krings G, Schuler P, Greutmann M, Hürlimann D, Yegitbasi M, Pons L, Gramlich M, Drenckhahn JD, Heuser A, Berger F, Jenni R, Thierfelder L. Circulation; 2008 Jun 03; 117(22):2893-901. PubMed ID: 18506004 [Abstract] [Full Text] [Related]
6. Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction. Timmer SA, Germans T, Brouwer WP, Lubberink M, van der Velden J, Wilde AA, Christiaans I, Lammertsma AA, Knaapen P, van Rossum AC. Eur J Heart Fail; 2011 Dec 03; 13(12):1283-9. PubMed ID: 22021246 [Abstract] [Full Text] [Related]
12. Microsatellite marker analysis in the treatment and diagnosis of familial hypertrophic cardiomyopathy. Smolik S, Domal-Kwiatkowska D, Kapral M, Weglarz L. Acta Pol Pharm; 2010 Mar 03; 67(6):669-72. PubMed ID: 21229884 [Abstract] [Full Text] [Related]
14. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. Kubo T, Gimeno JR, Bahl A, Steffensen U, Steffensen M, Osman E, Thaman R, Mogensen J, Elliott PM, Doi Y, McKenna WJ. J Am Coll Cardiol; 2007 Jun 26; 49(25):2419-26. PubMed ID: 17599605 [Abstract] [Full Text] [Related]
18. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy. Weissler-Snir A, Hindieh W, Gruner C, Fourey D, Appelbaum E, Rowin E, Care M, Lesser JR, Haas TS, Udelson JE, Manning WJ, Olivotto I, Tomberli B, Maron BJ, Maron MS, Crean AM, Rakowski H, Chan RH. Circ Cardiovasc Imaging; 2017 Feb 26; 10(2):. PubMed ID: 28193612 [Abstract] [Full Text] [Related]
19. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. Maron BJ, Maron MS, Semsarian C. J Am Coll Cardiol; 2012 Aug 21; 60(8):705-15. PubMed ID: 22796258 [Abstract] [Full Text] [Related]